News About: Pharm. Industry
Green Cross’s Hepabig-Gene gets orphan drug designation
Green Cross Corp. said last Thursday that Hepabig-Gene, a recombinant antibody for hepatitis B, was designated as an “orphan drug” by the United States Food and Drug Administration (FDA).
The FDA provides orphan dr...
Korea International Pharmaceutical Ingredient Exhibition to open
Buyers from 70 companies in China, India, Malaysia, Singapore and Mongol will meet 70 pharmaceutical firms in Korea during an international exhibition on a variety of products, including fine chemicals, cosmetic produ...
Government to launch 100 billion won fund for pharmaceutical firms
The government will launch a 100 billion won pharmaceutical fund in August to help local companies develop advanced technology and expand to overseas markets, according to the Ministry of Health and Welfare.
The mi...
Pharmaceutical firms urged to take lead in bio industries
Korean drug companies should invest massively in bio industries to grab a slice of the rapidly growing market, the Ministry of Food and Drug Safety (MFDS) said Tuesday.
In an information session hosted by the MFDS ...
Sales executives grapple with lackluster sales
Pharmaceutical companies, large or small, are continuing to grapple with a low growth in the first quarter of the year due largely to sluggish sales in the domestic market, according to Yakup.com, a pharmaceutical inf...
Legal battle over educational videos seen to be intensifying
Dong-A Pharmaceutical Co. admitted most of its wrongdoings in its third court hearing Monday. The company was indicted on the charge of offering illegal rebates worth some 4.8 billion won to 119 doctors.
But Dong-A...
More firms suffer from lackluster sales in first quarter
Korea’s drug companies saw their first-quarter revenues drop compared to the last quarter due to the policy, geared toward eliminating the illegal kickbacks from drug firms to doctors and pharmacists.
According to ...
Drugmakers, wholesalers urged to promote mutual growth
The controverial Namyang case is a typical example vividly showing how small business owners are suffering distress from unfair and illegal business practices at the hands of their bigger partners. It’s lamentable to ...
19 doctors to face court hearing for illegal kickbacks
The first court hearing on 19 doctors, who was indicted on charge of illicit drug kickbacks, will be held today.
In March, the prosecution summoned 119 doctors for receiving inappropriate favors from Dong-A Pharmac...
Green Cross’s U.S. partner gets 'orphan drug' designation for novel anticancer drug
Green Cross Corp. said last Friday that JX-594 (pexastimogene devacirepvec), an investigational medicine its U.S. business partner Jennerex Biotherapeutics developed for patients suffering from hepatocellular carcinom...
